In vitro Evaluation of the Essential Oil Extract of Six Plant Species and Ivermectin on the Microfilaria Larva of Simulium yahense
E. M. Ilondu,
A comparative laboratory bioassay of the essential oil extracts of M. koenigii
(seed), Citrus paradisi (seed) and the leaves, stem barks and roots of
Alstonia boonei, Alternanthera repens, Eclipta prostrata and Rothmannia
longiflora and their combination were compared with ivermectin against the
third infectious microfilaria larva of Simulium yahense. Bioassay test
showed remarkable larvicidal properties for ivermectin and the plant species under
study as they could induce significant mortalities at low and varying concentrations
in the larva of S. yahense. The LC50 and LC90 values
estimated for M. koenigii, Citrus paradisi, Alstonia boonei, Alternanthera
repens, Eclipta prostrata, Rothmannia longiflora, their combination and ivermectin
are 5.75 and 13.18, 8.38 and 15.49, 3.02 and 15.49, 2.472 and 9.33, 2.87 and 12.88,
2.93 and 13.49, 2.61 and 3.16 and 2.43 and 5.37 ppm, respectively. The study revealed
that ivermectin and the combination of the plant extracts could induce 100% mortality
of the larva at a dose dependent response.
Received: November 05, 2011;
Accepted: December 26, 2011;
Published: March 15, 2012
Onchocerciasis is an infestation with filarial worms of the genus Onchocerca,
common in tropical America and Africa, transmitted by black flies and characterized
by nodules under the skin, an itchy rash, eye lesions and in severe cases, elephantiasis.
The principal clinical manifestations are ocular lesions, resulting in visual,
impairment and blindness and Onchocercal Skin Disease (OSD) (Murray
and Lopez, 1996). Szirmai (2005) estimated that West
Africa share about 30% of global cases of onchocerciasis with 96% of reported
cases globally occurring in Africa. More so, this disease burden has contributed
significantly to increased incidence of eye defects in tropical West Africa.
For example Dadzie et al. (1989) reported an
onchocerciasis prevalence ratio of 1:3 to other ocular problems in North central
and North eastern part of Nigeria. Like most other diseases, majority of infestation
cases are hardly reported nor documented. Over the years, control and management
of the larvicidal activities of this epidemic has been achieved with diethyl
carbamazine and most notably with ivermectin. Ivermectin marketed under the
brand name Stromectol is administered orally and available in 3 mg tablets containing
microcrystalline cellulose, pregelatinized starch, magnesium separate, butylated
hydroxyanisole and citric acid powder (anhydrous). It is derived from the avermectins,
a class of highly active broad-spectrum, anti-parasitic agents isolated from
the fermentation products of Streptomyces avermitilis. It is a white
to yellowish-white, nonhygroscopic, crystalline powder with a melting point
of about 155°C. It is insoluble in water but is freely soluble in methanol
and soluble in 95% ethanol. The required dosages for patients between ages 15-25,
26-44, 46-64, 65-84 and above 84 are one, two, three, four and 150 mcg kg-1
of 3 mg tablets, respectively. However, clinical studies have shown that stromectol
(ivermectin) has no activity against adult Onchocerca volvulus parasites
since they reside in subcutaneous nodules which are infrequently palpable. Surgical
excision of these nodules (nodulectomy) is often considered in the management
of patients with onchocerciasis, since this procedure will eliminate the microfilaria-producing
adult parasites (Ali et al., 2003). More so,
the use of this drug is fraught with vision changes, urinary or bowel problems,
weakness, confusion, lack of coordination, eye redness, swelling, pain or seizure
(convulsions) (De Sole et al., 1989, 1991).
It is in view of these shortcomings, that researches using cheap, readily available
and negligible side effects from natural plant products are being championed
by the Federal Ministry of Health in Nigeria. At the moment, priority is being
paid to the application of these natural plant products through the use of larvicides
and ovicides as ideal control measures. Natural products and secondary metabolites
formed by living systems, notably from plant origin, have shown great potentials
in treating human diseases such as cancer, coronary heart diseases, diabetes,
malaria and infectious diseases. It is against this back drop that this study
aims at evaluating the larvicidal properties of these six plant species, their
combination and ivermectin against the infectious larva stage of S. yahense.
In the present investigation, specific action of each plant, their combination
and ivermectin were evaluated against the third infectious stage (microfilaria)
of S. yahense.
MATERIALS AND METHODS
Sample collection: Six medicinal plants were collected from Ugbodu in
Aniocha North local government area of Delta state, Nigeria. Seven herbalists
from randomly selected communities in the area were interviewed on their methods
of treatment of onchocerciasis which is prevalent in the area. After the interview
six plants M. koenigii (seed), Citrus paradisi (seed) and the
leaves, stem barks and roots of Alstonia boonei, Alternanthera repens, Eclipta
prostrata and Rothmannia longiflora were mentioned as anti-onchocerciasis
herbs and two seeds were mentioned as possessing anti larvicidal properties.
All of them were unanimous in their use of the herbs in combination for enhanced
efficacy and their mode of preparation of the herbs (boiling or maceration in
alcohol). The seeds of the plants were obtained through the help of two herbalists
from the village forest. In addition, their respective leaves and stems together
with those of the other mentioned plant species were collected for botanical
identification. The identification and authentication was done at the herbarium
unit of the Department of Botany, University of Calabar, Nigeria, where a voucher
specimen was deposited.
Methods: The freshly collected plant specimens were washed thoroughly, weighed and chopped off finely and subjected to hydro-distillation in a Clevengers apparatus in order to obtain its vaporizing essential oils. The oil color ranged from yellow through red to dark brown and black, with a moderate to low viscosity and a yield of 2.438, 2,745, 2.314, 4.311 3.845, 3.362 and 6.497 mL kg-1 weight of the starting material. The oil was then dissolved in acetone in a ratio of 1:1. A series of concentrations ranging from 3-15 ppm of the dissolved oil were prepared in distilled water. Similarly, 3 mg tablets of ivermectin were grounded to powder and used to prepare similar concentrations to that of the plants essential oil. Three replicates were run for each concentration and the plant extract/ivermectin. The oil obtained was stored in screw capped vials at laboratory conditions until tested. Control tests were carried out in parallel with the required amount of acetone in water. The extraction was carried out n the department of Biochemistry, UNICAL.
Supply of ivermectin: Ivermectin was obtained as a classified drug with No. 8495 and supplied as NDC 0006-0032-20, with unit dose packages of 20, storage temperature below 30°C (86°F) and an expiring shelf life of 06-09-2012. STROMECTOL (ivermectin) 3 mg are white, round, flat, bevel-edged tablets coded MSD on one side and 32 on the other side, distributed by MERCK and CO., INC, Whitehouse Station, NJ 08889, USA and manufactured by MSD BV Waarderweg 39 2031 BN Haarlem Netherlands.
Larva collection and laboratory bioassay: The microfilaria larvae were
prepared and obtained from Nigeria Institute for pharmaceutical research and
development, Idu, Abuja. Pure culture of the larva containing twenty-five microfilaria
each were prepared and stored in glass vials at 27±0.2°C. The larvae
were provided a mixture of Dog biscuit, yeast powder and algae in a ratio 3:1:1
ratio. Twenty-five larvae were released into 500 mL glass beakers and supplemented
with treatments by taking 3.0, 6.0, 9.0, 12.0 and 15.0 ppm of plants essential
oil and ivermectin, respectively. Mortally counts were made after 24 h exposure.
Bioassay test showing more than 15% control mortality was discarded and repeated.
However, when control mortality ranged from 5-15%, the corrected mortality was
corrected using Schneider-Orellis formula (Puntener, 1981).
The data obtained were subjected to probit analysis in order to estimate the
LC50 and the heterogeneity values (Finney, 1952).
The experiment was carried out at 27±0.2°C.
RESULTS AND DISCUSSION
Nowadays, the trend in the control and management of infectious diseases is
directed against larval and only against adult when necessary (McConnell
et al., 2010). This is because the fight against adult is temporary,
unsatisfactory and polluting for the environment, while larval treatment is
more localized in time and space resulting in less dangerous outcomes. Larval
control and the use of natural products can be an effective tool in onchocerciasis
management since clinical studies has shown that Stromectol (ivermectin) has
no activity against the adult stage (Burnham, 1995).
In the present study, the test revealed that at concentrations of 9, 12 and
15 ppm of the essential oil extract combination, Alternanthera repens
and ivermectin, could induce 100% larval mortality. The larvicidal responses
of the two remedies were shown to be dose dependent. The data obtained was subjected
to probit analysis in order to estimate the LC50 and LC90
and heterogeneity values. The LC50 and LC90 values estimated
for M. koenigii, Citrus paradisi, Alstonia boonei, Alternanthera repens,
Eclipta prostrate, Rothmannia longiflora, their combination and ivermectin
are 5.75 and 13.18, 8.32 and 15.49, 3.02 and 15.49, 2.61 and 9.33, 2.87 and
12.88, 2.93 and 13.49, 2.47 and 5.46 and 2.43 and 5.37 ppm. The essential oil
of the combination remedy was found to be relatively more toxic to the microfilaria
larva (1:1), followed by that of Alternanthera repens (2:1) while the
activity of Murruya koenigii oil extract was shown to be relatively least
active (3:1) when compared to ivermectin.
The calculated chi-square values for ivermectin, combination, Rothmannia longiflora and Alternanthera repens are less than table values at 0.05% (Table 1) indicating random variations among the doses for the aforementioned remedies.
||Dosage response of the essential oil of six plant species,
their combination and ivermectin against the microfilaria larvae of Simulium
|Ppm: parts per million; LC50: Lethal concentration
needed to kill 50% of larva exposed; LC90: Lethal concentration
needed to kill 90% of larva exposed; *df: Degree of freedom; χ2:
Chi-square for heterogeneity
Previous literatures on larvicidal control of microfilaria have been carried
out through spraying of endemic breeding sites over a long-distant range (Remme,
2004). Other control measures include, epidemiological modeling (Remme
et al., 1995), research on disease patterns and community trials
of ivermectin (WHO, 1995). Such control measures are
either subjective, environmentally hostile or fail to achieve target objective.
There have been dearths of published works on the use of natural products of
plant origin in the larvicidal control of onchocerciasis.
This study indicates that the essential oil extract of M. koenigii, Citrus paradisi and the the leaves, stem barks and roots of Alstonia boonei, Alternanthera repens, Eclipta prostrata and Rothmannia longiflora and their combination and ivermectin has remarkable larvicidal activity against Simulium yahense. It is noteworthy to study extensively the larvicidal properties of the essential oils contained in the plants by isolating and identifying the active ingredients that cause larval mortality and then use them in field trials in order to assess their potentials as alternative to ivermectin and other chemical larvicides whose activities are being reviewed.
We appreciate the contributions of Dr. Kolo Ibrahim of the Nigeria Institute of Pharmaceutical Research and Development, Idu, Abuja for providing the larva. Also, we appreciate the inputs of Prof, J.M.O. Eze, of Novena University, Ogume.
1: Ali, M.M., O.Z. Baraka, S.I. AbdelRahman, S.M. Sulaiman, J.F. Williams, M.M. Homeida and C.D. Mackenzie, 2003. Immune responses directed against microfilariae correlate with severity of clinical onchodermatitis and treatment history. J. Infect. Dis., 187: 714-717.
2: Burnham, G., 1995. Ivermectin treatment of onchocercal skin lesions: Observations from a placebo-controlled, double-blind trial in Malawi. Am. J. Trop. Med. Hyg., 52: 270-276.
3: Dadzie, K.Y., J. Remme, A. Rolland and B. Thylefors, 1989. Ocular onchocerciasis and intensity of infection in the community. II. West African rainforest foci of the vector Simulium yahense. Trop. Med. Parasitol., 40: 348-354.
4: De Sole, G., J. Remme, K. Awadzi and S. Accorsi, 1989. Adverse reactions after large-scale treatment of onchocerciasis with ivermectin: Combined results from eight community trails. Bull. World Health Org., 39: 137-146.
5: De Sole, G., R. Baker, K.Y. Dadzie, J. Giese, P. Guillet, F. M. Keita and J. Remme, 1991. Onchocerciasis distribution and severity in five West African countries. Bull. World Health Organ., 69: 689-698.
Direct Link |
6: Finney, D.J., 1952. Probit Analysis. Cambridge University Press, Cambridge, pp: 333
7: McConnell, M.S., M. Balasubramani, K. Rajan and I.A.J. Gerald, 2010. Evaluation of the larvicidal activity of the leaf extracts of Duranta erecta Linn. (Verbenaceae) on the larvae of Culex quinquefascitatus (Say) (Culicidae). J. Biopesticides, 3: 582-585.
8: Murray, C.J.L. and A.D. Lopez, 1996. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries and Risk Factors in 1990 and Projected to 2020. 1st Edn., Harvard School of Public Health, Cambridge, ISBN-13: 978-0674354487, Pages: 1022
9: Puntener, W., 1981. Manual for Field Trials in Plant Protection. 2nd Edn., Agricultural Division, Ciba-Geigy Limited, Basle
10: Remme, J.H.F., E.S. Alley and A.P. Plaisier, 1995. Estimation and Prediction in Tropical Disease Control: The Example of Onchocerciasis. In: Epidemic Models: Their Structure and Relation to Data, Mollison, D. (Ed.). Cambridge University Press, Cambridge, pp: 372-392
11: Remme, J.H.F., 2004. Research for control: The onchocerciasis experience. Trop. Med. Int. Health, 9: 243-254.
12: Szirmai, A., 2005. Dynamics of Socio-Economic Development: An Introduction. Cambridge University Press, Cambridge, ISBN: 9780521817639, pp: 233
13: WHO, 1995. Onchocerciasis and its control. Report of a WHO expert committee on onchocerciasis control. World Health Organization Technical Report Series, 852, pp: 1-104.